SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-057838
Filing Date
2017-11-09
Accepted
2017-11-09 17:18:24
Documents
7
Period of Report
2017-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv478872_8k.htm 8-K 31446
2 EXHIBIT 4.1 tv478872_ex4-1.htm EX-4.1 531733
3 EXHIBIT 4.2 tv478872_ex4-2.htm EX-4.2 37330
4 EXHIBIT 4.3 tv478872_ex4-3.htm EX-4.3 37166
5 EXHIBIT 4.4 tv478872_ex4-4.htm EX-4.4 37324
6 EXHIBIT 5.1 tv478872_ex5-1.htm EX-5.1 10162
7 GRAPHIC tv478872_ex5-1logo.jpg GRAPHIC 4126
  Complete submission text file 0001144204-17-057838.txt   692200
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34912 | Film No.: 171191948
SIC: 2834 Pharmaceutical Preparations